Home > Surgical Equipment and Services

Surgical Equipment and Services

 

Facet expands US pivotal study of next generation implant system

Facet Solutions expands its ACADIA Facet Replacement Pivotal Study for the treatment of lumbar spinal stenosis to 12 sites in the USA.

28 April 2009: Facet Solutions

 

New radiation treatment planning software offers VMAT flexibility

Available as a module in Philips Pinnacle3 version 9 radiation treatment planning (RTP) software, the new planning option can be used with any VMAT-capable delivery system on the market.

27 April 2009: Philips Medical Systems

 

OrbusNeich's stent technology presents 12 month follow up results

Margo Klomp, MD from the Academic Medical Center (AMC), Amsterdam, The Netherlands, reports on OrbusNeich's pro-healing stent technology when presenting final adjudicated 12 month follow up results from the randomized AMC single centre TRIAS High Risk (HR) study showed a slightly higher target lesion revascularization (TLR) rate with the Genous treated patient group compared with patients receiving the Taxus drug eluting stent.

27 April 2009: OrbusNeich

 

MAGNET agrees to purchase Elekta's oncology delivery systems

One of the largest non-profit group purchasing organizations (GPO) in the USA, MAGNET Cooperative, signs a sole source agreement with Elekta, enabling its members to begin purchasing Elekta's oncology delivery systems.

24 April 2009: Elekta

 

Facet publishes one-year data for lumbar spinal stenosis treatment

Facet Solutions announces the publication of its one-year data for the ACADIA US Pilot Clinical Study which utilised the ACADIA Facet Replacement System for the treatment of lumbar spinal stenosis.

24 April 2009: Facet Solutions

 

Swiss cancer patient is treated with RapidArc radiotherapy on a Novalis Tx platform

A 51-year old female cancer patient from Switzerland is the first patient outside the USA to be treated with RapidArc radiotherapy technology from Varian Medical Systems on a Novalis Tx platform for radiosurgery and radiotherapy.

23 April 2009: Varian

 

Yashoda Cancer Institute begins treating patients with RapidArc radiotherapy system

Clinicians in India carry out the country's first treatment using a new, faster form of radiotherapy that extends more advanced care to more patients.

22 April 2009: Varian

 

New uterine robotic surgery trainer permits unlimited practice

The Chamberlain Group is introducing a new Uterine Robotic Surgery Trainer which is a lifelike, full-scale model of the human uterus and vaginal canal.

22 April 2009: The Chamberlain Group

 

Mind Research Network installs Elekta Neuromag to measure brain activity

The Mind Research Network (MRN) is installing an Elekta Neuromag, a device for non-invasive measurement of brain activity using Magnetoencephalography (MEG) technology.

21 April 2009: Elekta

 

Medtronic receives Japanese MHLW approval for Talent Thoracic Stent Graft

Medtronic receives regulatory approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) for the Talent Thoracic Stent Graft, a lifesaving technology that allows more patients to benefit from a minimally-invasive treatment for certain types of aneurysms of the descending thoracic aorta.

15 April 2009: Medtronic

 

Medtronic begins ENGAGE study to evaluate the Endurant stent graft

Medtronic starts ENGAGE, the largest ever study of its kind, which will evaluate the performance of the Endurant stent graft, an implantable medical device designed to provide an advanced minimally-invasive alternative to open surgical repair of abdominal aortic aneurysms.

14 April 2009: Medtronic

 

Ekrior is appointed Portuguese distributor for Misonix surgical instruments

Misonix enters into a new, three year, exclusive distribution agreement with Ekrior Lda, a Division of Avanco Sistemas Medicos, based in Barcarena, Portugal, for the distribution of the SonaStar Ultrasonic Surgical Aspirator, the BoneScalpel Ultrasonic Bone Cutter, and the SonicOne Ultrasonic Wound Debrider.

14 April 2009: Misonix

 

Study highlights benefits of DuraHeart LVAS device for heart transplantation

A new study of the DuraHeart Left Ventricular Assist System (LVAS) shows sustained benefits in providing safe and reliable long-term circulatory support with an improved survival rate and an acceptable adverse event rate in advanced heart failure patients who were eligible for transplantation.

10 April 2009: Terumo Heart

 

New endograft from Cook offers controlled treatment of thoracic aortic aneurysms

Patients undergoing endovascular repair of thoracic aneurysms are receiving the clinical benefits of Cook Medical's new Zenith TX2 TAA Endovascular Graft with Pro-Form for more controlled treatment of thoracic aortic aneurysms (TAAs).

07 April 2009: Cook

 

The first patients in India start treatment using CyberKnife radiosurgery system

The first patients in India are being treated using Accuray’s CyberKnife radiosurgery system, which is located at the Apollo Specialty Cancer Hospital in Chennai, India.

06 April 2009: Accuray

 

Medtronic plans global launch of Driver Sprint RX Coronary Stent System

Medtronic is launching the Driver Sprint RX Coronary Stent System, which received the CE Mark in February 2009 and is planned to be commercially available in more than 100 countries worldwide.

03 April 2009: Medtronic

 

Abbott initiates US clinical trial of the Absolute Pro Peripheral Self-Expanding Stent

Abbott initiates MOBILITY, a clinical trial in the USA that is studying the safety and efficacy of the Absolute Pro Peripheral Self-Expanding Stent System in patients with iliac artery disease.

02 April 2009: Abbott Vascular

 

Swiss and German hospitals begin treating cancers with RapidArc radiotherapy

Leading University Hospitals in Germany and Switzerland are commencing treatments for complex cancers, including head and neck tumours, using RapidArc radiotherapy technology from Varian Medical Systems.

01 April 2009: Varian

 

MEDICAL DEVICE TECHNOL0GY – MARKET ANALYSIS

FOCUS ZONE REPORT – Market conditions in the medical device technology sector are driving two key trends that look like they will be overlapping during 2009 and the outcome is that a new spate of acquisitions are likely to be auctioned throughout the year.

31 March 2009: Medtronic

 

One-year data is released from SYNTAX trial of Taxus Express2 stent system

Boston Scientific announces results from an analysis of economic and quality of life outcomes, based on one-year data from its landmark SYNTAX trial.

30 March 2009: Boston Scientific

 

Results from SPIRIT II and III Trials indicate safety and efficacy of stent solutions

Three-year results from the SPIRIT II Clinical Trial and a pooled meta-analysis of two-year data from the SPIRIT II and III Trials have been at the 58th Annual Scientific Session of the American College of Cardiology.

30 March 2009: Boston Scientific

 

Abbott's SPIRIT II clinical trial demonstrates long term data

Long-term data from Abbott's SPIRIT II clinical trial demonstrates that the clinical advantages of the Xience V Everolimus Eluting Coronary Stent System continued to increase between two and three years compared to the Taxus Express2 Paclitaxel-Eluting Coronary Stent System / Taxus Liberte Paclitaxel-Eluting Coronary Stent System (Taxus).

30 March 2009: Abbott Vascular

 

NovaLign receives 510(k) clearance for Intramedullary Fixation System

NovaLign Orthopaedics receives its first 510(k) clearance from the US Food and Drug Administration to market its Intramedullary Fixation System, a new system of implants and instruments for the treatment of long bone fractures, including the humerus, tibia and femur.

27 March 2009: NovaLign Orthopaedics

 

Deep brain stimulation system sees first patient implants to treat Parkinson’s disease

St Jude Medical announces the first patient implants of its Libra deep brain stimulation (DBS) system for treating the symptoms of Parkinson’s disease, a progressive neurological disorder that affects a person's control over his or her movements and speech.

27 March 2009: St Jude Medical

 

Five-year study confirms durability of hernia graft design

A five-year study confirms the long-term strength and durability of Cook Medical’s Biodesign Hernia Graft.

24 March 2009: Cook

 
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30
 

 

 

© 2010 ProHealthServiceZone.com